Presence of thiamine pyrophosphate in mammalian peroxisomes by Fraccascia, Patrizia et al.
BioMed  Central
Page 1 of 6
(page number not for citation purposes)
BMC Biochemistry
Open Access Research article
Presence of thiamine pyrophosphate in mammalian peroxisomes
Patrizia Fraccascia, Mieke Sniekers, Minne Casteels and Paul P Van 
Veldhoven*
Address: Department of Molecular Cell Biology, Division of Pharmacology, LIPIT, Katholieke Universiteit Leuven, O&N1, Herestraat 49, box 601, 
3000 Leuven, Belgium
Email: Patrizia Fraccascia - patrizia.fraccascia@med.kuleuven.be; Mieke Sniekers - mieke.sniekers@med.kuleuven.be; 
Minne Casteels - minne.casteels@med.kuleuven.be; Paul P Van Veldhoven* - paul.vanveldhoven@med.kuleuven.be
* Corresponding author    
Abstract
Background:  Thiamine pyrophosphate (TPP) is a cofactor for 2-hydroxyacyl-CoA lyase 1
(HACL1), a peroxisomal enzyme essential for the α-oxidation of phytanic acid and 2-hydroxy
straight chain fatty acids. So far, HACL1 is the only known peroxisomal TPP-dependent enzyme in
mammals. Little is known about the transport of metabolites and cofactors across the peroxisomal
membrane and no peroxisomal thiamine or TPP carrier has been identified in mammals yet. This
study was undertaken to get a better insight into these issues and to shed light on the role of TPP
in peroxisomal metabolism.
Results: Because of the crucial role of the cofactor TPP, we reanalyzed its subcellular localization
in rat liver. In addition to the known mitochondrial and cytosolic pools, we demonstrated, for the
first time, that peroxisomes contain TPP (177 ± 2 pmol/mg protein). Subsequently, we verified
whether TPP could be synthesized from its precursor thiamine, in situ, by a peroxisomal thiamine
pyrophosphokinase (TPK). However, TPK activity was exclusively recovered in the cytosol.
Conclusion: Our results clearly indicate that mammalian peroxisomes do contain TPP but that no
pyrophosphorylation of thiamine occurs in these organelles, implying that thiamine must enter the
peroxisome already pyrophosphorylated. Consequently, TPP entry may depend on a specific
transport system or, in a bound form, on HACL1 translocation.
Background
Thiamine (vitamin B1) is a water-soluble micronutrient
essential for normal cellular functions, growth and devel-
opment. Humans, and other higher eukaryotes, cannot
synthesize thiamine but depend on an appropriate dietary
intake and absorption of this vitamin. Its plasma concen-
tration is regulated by intestinal and renal mechanisms
which play a crucial role in regulating body thiamine
homeostasis. Upon entry into cells, thiamine is quickly
converted to its biologically active form, thiamine pyro-
phosphate (TPP) by thiamine pyrophosphokinase (TPK).
TPP plays a critical role in the carbohydrate and energy
metabolism. It functions as a prosthetic group for the
mitochondrial enzyme complexes like pyruvate dehydro-
genase,  α-ketoglutarate dehydrogenase and branched-
chain  α-keto acid dehydrogenase. In addition, TPP is
involved in the cytosolic pentose pathway functioning as
coenzyme for transketolase. Recently, it became clear that
TPP is also important for a less well known pathway,
namely the α-oxidation of 3-methyl-branched and
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straight chain 2-hydroxy long chain fatty acids [1-3]. In
this pathway, which is confined to peroxisomes, TPP,
together with Mg2+, is required for the proper functioning
of 2-hydroxyphytanoyl-CoA lyase (2-HPCL), recently
renamed to 2-hydroxyacyl-CoA lyase 1 (approved gene
symbol and protein product HACL1) [4]. This peroxiso-
mal matrix protein acts as a tetramer and catalyzes the
cleavage of 2-hydroxyphytanoyl-CoA and 2-hydroxy long
chain acyl-CoA into formyl-CoA and an aldehyde short-
ened by one carbon [1,5]. So far, HACL1 is the only
known peroxisomal TPP-dependent enzyme in mam-
mals.
The importance of TPP/thiamine in the α-oxidation path-
way is stressed by the deleterious effects seen in rats given
a thiamine-deficient diet enriched in phytol [3]. Phytol is
the precursor of phytanic acid and is, under normal con-
ditions, converted to pristanic acid and further β-oxidized
in peroxisomes. In thiamine deficient rats, however, phy-
tol administration results in death [3]. Presently nothing
is known about the transport of thiamine or its phosphate
esters across the peroxisomal membrane. Hence, we ana-
lyzed the presence of this vitamin in peroxisomes and ver-
ified whether peroxisomes are able to synthesize it starting
from thiamine.
Results and discussion
Studies on the distribution of thiamine and its phosphate
esters in animal tissues appeared in the literature a few
decades ago. In rat, the distribution of this vitamin has
been shown to be tissue specific [6,7]. So far, most consist-
ent data are available for rat brain [7,8], while less is
known about the subcellular localization in rat liver. With
regard to TPP, its content in rat brain is reported to be
highest in mitochondrial and synaptosomal fractions [8],
whereas in skeletal muscle [9] and rat liver [10] most TPP
is reported as cytosolic.
Since the discovery of the TPP-dependent HACL1, it
became clear that TPP, and in general the thiamine status
of the cell [3], plays an important role in peroxisomal α-
oxidation. Until now, TPP has never been measured in
peroxisomes, nor has its transport over the peroxisomal
membrane been considered. This study was undertaken to
address these issues.
In mouse and rat liver homogenates, prepared in the pres-
ence of phosphatase inhibitors, TPP and thiamine were
found to be more abundant than TMP (data not shown).
The amount of TPP measured in mouse and rat liver
homogenates was 55 and 26 nmol/g liver, respectively
(mean of two experiments). The latter value is comparable
with previously published data [6]. When analyzing sub-
cellular fractions of rat liver, about 50% of the TPP was
recovered in the cytosol (Figure 2A), which is also in
agreement with previous data [10]. The light mitochon-
drial fraction L, enriched in peroxisomes and lysosomes,
contained only 3% of total hepatic TPP and, when related
to its protein content, did not display an enrichment (Fig-
ure 2A). However, after separating the L-fraction on a
Nycodenz gradient, the majority of TPP sedimented
together with catalase and urate oxidase, markers for per-
oxisomes, to a high density (Figure 3A–D). As expected
[1], HACL1 was also recovered in the peroxisomal frac-
tions (Figure 3B). In the fraction that, based on the cata-
lase measurement, was mostly enriched in peroxisomes,
TPP increased to 177 ± 2 pmol/mg protein (mean ± SEM
of three experiments), about twofold more in comparison
with the L-fraction (79.4 ± 11 pmol/mg protein). Assum-
ing that the peroxisomal compartment accounts for 2–
2.5% of the total hepatic protein content [11,12] and
occupies approximately 10 μl per ml of liver [13,14], one
can estimate the intraperoxisomal TPP concentration at
approximately 65–85 μM. As part of the TPP may leak out
of peroxisomes during the fractionation procedure, this
value represents a minimal estimation, but appears to be
higher than the cytosolic concentration, estimated at 15–
20 μM assuming that the cytosol accounts for 80% of the
hepatocyte volume [13]. So on the whole, we can con-
clude that the peroxisome is a TPP-containing cell com-
partment that accounts for 2–3% of the total hepatic TPP
content. Generally, isolated mammalian peroxisomes are
devoid of cofactors, given the leaky nature of their mem-
brane after tissue homogenization [15,16]. TPP would be
the second example of a cofactor pool, the first one being
CoA [17]. Preliminary data indicate that most of the per-
oxisomal TPP is not in a free form. Indeed, when freeze-
thawed peroxisomes were subjected to ultrafiltration
(Minicon, 10 kDa cut off membrane), only 17% of perox-
isomal TPP was recovered in the ultrafiltrate. When the
organelles were sonicated in the presence of 0.5% (w/v)
Triton X-100 in order to disrupt the phospholipid bilayer,
this value increased to 37%. These results suggest that
most TPP is tightly bound to peroxisomal proteins, most
likely to HACL1, or membranes. During its purification
from rat liver, HACL1 appeared to gradually lose bound
TPP and its activity could be restored by adding TPP and
MgCl2 to the assay mixture [1].
The presence of TPP in peroxisomes raises the question
whether thiamine or TPP is transported across the peroxi-
somal membrane. Transport of thiamine over the plasma
membrane is performed by the high affinity carriers
ThTR1 and ThTR2, encoded by the SLC19A2  and
SLC19A3 gene, respectively. This transport system would
also be present in the mitochondrial membrane [18] but
nothing is known about a peroxisomal transporter.
Uptake of thiamine would require a peroxisomal TPK to
convert the vitamin into active TPP. To investigate the
presence of such a kinase, we analyzed whether TPP couldBMC Biochemistry 2007, 8:10 http://www.biomedcentral.com/1471-2091/8/10
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be formed from thiamine intraperoxisomally. The TPK
activity profile overlapped with the distribution of lactate
dehydrogenase (LDH) activity (Figure 2B–C). As LDH is a
marker enzyme for the cytosol and TPK activity was absent
or too low to be measured reliably in the Nycodenz puri-
fied peroxisomes (data not shown), we can conclude that
TPK is exclusively cytosolic. This is in accordance with pre-
vious results [19,20,30] and with computer-based predic-
tion studies, which show no peroxisome targeting signal
in the primary amino acid sequence of mammalian TPK.
Thus, we can conclude that peroxisomal TPP is not the
product of an in situ pyrophosphorylation of thiamine,
suggesting that TPP has to enter the peroxisome as such.
Whether TPP is transported across the peroxisomal mem-
brane via a specific carrier has not been discovered yet. In
human mitochondria, Song and Singleton [18] detected a
saturable TPP transport system and the yeast mitochon-
drial counterpart has been functionally characterized [21].
Reversed phase separation of thiochrome derivatives of thia- mine and thiamine phosphate esters Figure 1
Reversed phase separation of thiochrome derivatives 
of thiamine and thiamine phosphate esters. Panel A. A 
mixture of derivatized standards (50 pmol each) was injected 
on a C18 amide column as described in Materials and Meth-
ods. The vitamins eluted in the following order: TPP (6.4 
min), TMP (7.2 min) and thiamine (10.4 min). Panel B. Chro-
matogram of the thiochromes generated from a peroxisome 
enriched fraction (3.1 mg protein/ml) obtained from the 
Nycodenz gradient (black line), documenting the presence of 
TPP. Some peaks apparently originate from Nycodenz, as 
revealed by comparison with the profiles of the correspond-
ing blank Nycodenz fractions, both derivatized (red line) and 
not derivatized (blue line).
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Subcellular distribution of TPP and TPK activity Figure 2
Subcellular distribution of TPP and TPK activity. The 
nuclear (N), heavy mitochondrial (M), light mitochondrial (L), 
microsomal (P) and cytosolic (S) fractions, obtained by frac-
tionation of a fresh rat liver homogenate, were analyzed for 
TPP content (panel A), TPK activity (panel B) and lactate 
dehydrogenase, marker enzyme for cytosol (panel C, LDH) 
and other marker enzymes (data not shown). Results are 
expressed as relative specific activities versus percentage of 
total protein. Relative specific activity is defined as the per-
centage of total recovered activity present in a particular 
fraction divided by the corresponding percentage of protein. 
Recoveries for TPP content (23 nmol/g liver) and LDH (456 
U/g liver) and TPK (263 nmol/g liver/h) activities were 128%, 
97% and 97%, respectively. Recoveries for GDH activity and 
protein content were 102% and 94%, respectively (data not 
shown). A second fractionation (data not shown) resulted in 
a similar histogram for TPP (28 nmol/g liver), but with some-
what more enrichment in the M-fraction (RSA 1.79) (recov-
ery 108%); other marker enzyme and protein recoveries 
varied between 70% to 102%. The TPP measured in the N-
fraction is partially due to unbroken and damaged cells, 
which are pelleted together with nuclei.
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More recently, mitochondrial TPP transport in mammals
has been linked to the deoxynucleotide carrier, a protein
encoded by the SLC25A19 gene, mutations in which cause
Amish lethal microcephaly [22].
In order to better understand peroxisomal metabolism, it
would certainly be useful to know more about the trans-
location mechanism of metabolites and cofactors across
the peroxisomal membrane. So far, evidence for func-
tional transporters in mammalian peroxisomes is limited
to ATP [23] and phosphate carriers [24]. With regard to
TPP, a carrier has not yet been identified, but one can also
envision that the uptake of this vitamin in peroxisomes is
linked with the import/tetramerization of HACL1.
Conclusion
Using HPLC coupled with fluorimetry, we detected and
measured, for the first time, the presence of TPP in puri-
fied rat liver peroxisomes. In addition, our results show
that peroxisomes are devoid of thiamine pyrophosphoki-
nase activity, which implies that vitamin B1 is entering the
peroxisome in its diphosphorylated form. The TPP trans-
port may be due to the existence of a specific peroxisomal
TPP carrier or it may be linked, as a cofactor-protein com-
TPP distribution in a light mitochondrial fraction after Nycodenz gradient centrifugation Figure 3
TPP distribution in a light mitochondrial fraction after Nycodenz gradient centrifugation. The light mitochondrial 
fractions obtained from rat liver were subjected to Nycodenz gradient centrifugation. Fractions were collected starting from 
the bottom. In a first experiment (panel A), TPP content (black line) and catalase activity (marker enzyme for the peroxisomal 
matrix; white bars) were measured. Recoveries for TPP content and catalase activity were 60% and 70%, respectively. Thia-
mine, which is also present in the L-fraction, was recovered in the top fractions (data not shown). The insert shows the density 
(g/ml) of the gradient. In a second experiment (panels B-D), HACL1 activity was measured (panel B; white bars; recovery 78%) 
revealing the highest activity (35 mU/mg protein) in fraction 6, corresponding to the TPP peak (180 pmol/mg protein, black 
line). In panels C and D, the distribution of LDH (marker for cytosol; recovery 121%) and urate oxidase (marker for peroxiso-
mal core; recovery 66%) is presented (white bars).
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plex, to the import of the peroxisomal TPP-dependent
enzyme HACL1.
Methods
Materials
Thiamine hydrochloride was purchased from Janssen
Chimica, TMP from Fluka and TPP from Sigma. Potas-
sium hexacyanoferrate [K3Fe(CN)6] was purchased from
Merck.
Animals
Animal studies were approved by the University Ethics
committee. Male Wistar rats, weighing approximately 200
g, and Swiss Webster mice, weighing approximately 30 g,
were maintained on a constant light-dark cycle and a
standard laboratory diet. Rats were fasted overnight before
sacrifice.
Preparation of homogenates and subcellular fractions
Homogenates of rat liver were prepared in 0.25 M sucrose
containing 5 mM Mops-NaOH, pH 7.2, 1 mM dithiothre-
itol and 0.1% (v/v) ethanol (homogenization medium).
Protease inhibitors were added to the homogenization
medium just before use. This medium was also supple-
mented with phosphatase inhibitors (5 mM NaF and 50
μM orthovanadate) to prevent degradation of TPP and
TMP. Subcellular fractionation into a nuclear (N), heavy
mitochondrial (M), light mitochondrial (L), microsomal
(P) and soluble (S) fraction was performed as described
previously [25]. Fraction L was subfractionated over a
Nycodenz gradient in order to obtain purified peroxi-
somes [26]. Marker enzymes and protein [25,27] and
HACL1 [5] were measured as described previously.
Determination of thiamine and its phosphate esters
Thiamine, TMP and TPP were analyzed by HPLC after
their conversion to a strongly fluorescent thiochrome
derivative by chemical oxidation in alkaline medium
(adapted from [6,28]). To remove particulate matter and
lipids, 100 μl sample was treated with 100 μl perchloric
acid (final concentration 0.4 M) and then centrifuged at
10,000 g at 4°C for 10 min. The supernatant (100 μl) was
immediately derivatized in subdued light with 20 μl 30
mM K3 [Fe(CN)6] in 15% NaOH. Methanol (10 μl) was
added to increase formation of thiochromes [28]. After 60
sec, the derivatization was stopped by adding 20 μl 1 M
H3PO4. Aliquots of 10 μl were injected on an Alltima HP
C18 amide column (150 × 4.6 mm; 5 μm; 190Å; Alltech),
connected to a Waters 1525 HPLC system coupled to a
Waters 2475 multi λ fluorescence detector (excitation and
emission wavelength 367 and 435 nm, respectively). The
mobile phase (1 ml/min) consisted of a gradient of K-
phosphate buffer (140 mM, pH 7)/12% methanol (buffer
A) to 70% methanol (buffer B). The analytical run started
with 100% buffer A; within 10 min, the ratio A/B reached
50/50, becoming 0/100 in the following 5 min. Using this
gradient, TPP, TMP and thiamine could be well separated
(Figure 1A). The addition of 1.5% N,N-dimethylforma-
mide (DMF) to buffer A, reported to result in better sepa-
ration [29], improved neither the separation nor the peak
shape of the three thiochromes in our hands. Moreover,
the baseline increased during elution when DMF was
present.
To investigate the stability of TPP in homogenates, mouse
liver was homogenized in sucrose medium and stored at -
20°C for 5 days. When prepared in the absence of phos-
phatase inhibitors, TPP levels dropped by approximately
42%, compared to the use of medium with inhibitors. The
amount of TPP measured in perchloric liver extracts or
homogenates made in the presence of inhibitors was com-
parable.
When analyzing samples containing Nycodenz, the base-
line was less stable and aberrant peaks were noticed that
interfered with the accurate determination of low levels of
TPP (< 1 pmol/sample). Apparently, these peaks origi-
nated from the tri-iodinated benzoate compound, but
their exact nature was unclear (Figure 1B). When required,
data were corrected by analyzing the corresponding frac-
tions collected from blank gradients.
Thiamine pyrophosphokinase activity measurement
Thiamine pyrophosphokinase activity was measured in
rat liver fractions. Samples (50 μl) were incubated at 37°C
with 8 mM thiamine, 24 mM ATP, 8 mM MgSO4 and 40
mM Na-phosphate buffer, pH 7.4 containing 5 mM NaF
and 0.1 mM orthovanadate as phosphatase inhibitors
(adapted from [30]). Final volume was 200 μl. After 1 h
incubation, 100 μl sample was treated with 100 μl per-
chloric acid and further processed as described above to
establish the amount of TPP formed. Values were cor-
rected for endogenous TPP by omitting thiamine from the
reaction mixture and used to calculate TPK activity, which
was expressed as nmol TPP produced/mg protein/h at
37°C.
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